ArticlePsychopharmacology2020

LMDS-1, a potential TrkB receptor agonist provides a safe and neurotrophic effect for early-phase Alzheimer's disease.

Chia-Hao Fan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.